Fitvia Corp.
BRZV · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 1.09 | 0.00 | 0.00 |
| FCF Yield | -0.00% | -0.00% | 0.19% | -6.64% |
| EV / EBITDA | -242.65 | -217.73 | -290.62 | -363.29 |
| Quality | ||||
| ROIC | 14.78% | 3.84% | 6.89% | 6.36% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.00 | 0.00 | -0.44 | 13.01 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -144.39% | -100.00% | 103.54% | -1,600.28% |
| Safety | ||||
| Net Debt / EBITDA | -20.79 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -14.10 |